Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.23.3
Stockholders’ Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2023
Jan. 31, 2018
Oct. 31, 2023
Oct. 31, 2022
Jul. 31, 2023
May 19, 2023
Jan. 31, 2011
Stockholders’ Equity (Details) [Line Items]              
Common stock, par value per share (in Dollars per share) $ 0.01   $ 0.01   $ 0.01 $ 0.01  
Offering price (in Dollars)     $ 30,000,000        
Aggregate Gross Proceeds Percentage     3.00%        
Sales agreement (in Dollars)         $ 150,000,000    
Common stock, shares issued 276,479       276,479    
Net Proceeds (in Dollars)         $ 386,000    
Common stock, shares issued     4,000,000        
Common stock granted     4,623,000        
Purchase shares of common stock     519        
Restricted stock units (RSUs) shares     367        
Total unrecognized compensation cost related to non-vested (in Dollars)     $ 839 $ 138      
Vested shares 144,530   10,640        
Restricted Stock Units award vest (in Dollars)     $ 173,333        
Share based compensation expense (in Dollars)     109,000 198,000      
Vest over fair market value (in Dollars)     $ 0 66,000      
2011 Plan [Member]              
Stockholders’ Equity (Details) [Line Items]              
Stock units             3,000,000
Shares of common stock   2,000,000          
Common stock available for grants   5,000,000          
Restricted Stock Units (RSUs) [Member]              
Stockholders’ Equity (Details) [Line Items]              
Common stock, shares issued     9,000,000        
Share based compensation expense (in Dollars)     $ 429,000 $ 186,000